LNC Therapeutics announces the grant of the first worldwide patent relating to the therapeutic...
Mar 26, 2019more +
We are looking for a R&D Microbiologist
Oct 13, 2020more +
LNC Therapeutics becomes YSOPIA Bioscience marking its transition to a clinical stage company
Sep 29, 2020more +
LNC Therapeutics Receives FDA Investigational New Drug Approval to Initiate a Phase 1 Clinical Trial...
Sep 8, 2020more +
Discovering the Therapeutic Potential of Keystone Bacteria in Treating Chronic Diseases
Apr 22, 2020more +
LNC Therapeutics announces the acquisition of an exclusive worldwide license on the first patent...
Apr 15, 2020more +
LNC Therapeutics Announces Successful GMP Manufacturing of Xla1 for Phase 1 Clinical Trial
Mar 12, 2020more +